Extinct Species Should Stay Extinct
By Ben A. Minteer,
Center for Humans and Nature
| 12. 01. 2014
The Center for Humans and Nature and The Hastings Center have partnered on a series called, How far should we go to bring back lost species? from which this article comes. See more here.
Untitled Document
For a species that’s been dead for a century, the passenger pigeon is having a pretty good year. A flurry of new books, features, and a major documentary has been roughly timed to commemorate the death of “Martha,” the last surviving member of the species that drew her final breath in the Cincinnati Zoo on Sept. 1, 1914. It’s a kind of national elegy for a bird that no one alive today remembers ever seeing, certainly not in the wild, where it was last spotted around the time shovels first broke ground on the New York subway system.
The
bird was a cheap and easily procured source of meat in the 18th and 19th centuries due to its astonishing abundance (once numbering in the billions) and its unfortunate tendency to travel in
massive flocks. Its fate was sealed...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...